Lasofoxifene cut breast ca by 81% in phase III trials: fractures decreased 24% at 0.5 mg/day.(NEWS): An article from: OB GYN News

This digital document is an article from OB GYN News, published by International Medical News Group on January 15, 2009. The length of the article is 642 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Lasofoxifene cut breast ca by 81% in phase III trials: fractures decreased 24% at 0.5 mg/day.(NEWS)
Author: Bruce Jancin
Publication:OB GYN News (Magazine/Journal)
Date: January 15, 2009
Publisher: International Medical News Group
Volume: 44 Issue: 2 Page: 1(2)

Distributed by Gale, a part of Cengage Learning